Aptamer Group plc (APTA) ORD GBP0.0001
- Add to watchlist
- Create an alert
- This stock can be held in a
Business summary
Aptamer Group plc is a developer of Optimer binders in the life sciences industry. It offers custom Optimer selection and development services. It delivers aptamer-based solutions to its customer bases for a range of therapeutic, diagnostic, and target-binding applications. It develops Optimer binders for therapeutics, diagnostics, bioprocessing, and research applications. The Optimer platform delivers aptamer tools that enables researchers and developers across the spectrum of the life sciences. Optimer binders has developed for a range of applications, including therapeutic inhibitors and modulators, drug delivery vehicles, protein purification and separation, biomarker screening and validation, in vitro research, quality control analysis, pharmacokinetic and drug assays, and in vitro diagnostic assays. Optimer act as agonists, antagonists, or cell-type-specific targeting moieties for the delivery of therapeutic agents to target cells and tissues in the treatment of disease.
Contact details
Important dates
General stock information
- EPIC:
- APTA
- ISIN:
- GB00BNRRP542
- Market cap:
- £3.97 million
- Shares in issue:
- 467.34 million
- Sector:
- No specific Industry
- Exchange:
- London Stock Exchange
- Currency:
- Sterling pence
- Indices:
- n/a
Key personnel
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.